Granules India Ltd is in Breakout from a long term channel
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.
CMP: 694.15
PE: 34.2
Debt to equity: 0.41
Since the valuation is reasonable and lower than Industry PE is giving attraction to this stock.
The zone upto 697.5 is acting as LOP zone in lower time frame analysis.
Since the Pharma sector is in a trending upward flow, this stock can be a good pick with best fundamentals.
Few qty can buy above 698 and further above 721 level at closing basis.
CMP: 694.15
PE: 34.2
Debt to equity: 0.41
Since the valuation is reasonable and lower than Industry PE is giving attraction to this stock.
The zone upto 697.5 is acting as LOP zone in lower time frame analysis.
Since the Pharma sector is in a trending upward flow, this stock can be a good pick with best fundamentals.
Few qty can buy above 698 and further above 721 level at closing basis.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.